Get Matched to Epilepsy Clinical Trials: Fast, Easy, and Personalized

Contribute to medical research and access clinical trials that match your unique health profile. Embleema makes the process seamless, secure, and personalized.

Get Started

Support Epilepsy Research and Find the Right Clinical Trial

At Embleema, we connect patients with clinical trials that match their unique health profiles. Our platform simplifies the process of finding relevant trials, making it easier for patients to contribute to medical advancements.

Begin by registering and completing the ‘My Epilepsy’ survey to share your unique epilepsy journey. Based on your responses, you may be matched with a relevant clinical trial.

Get Started

Home

About Us

Get Matched by Registering on Embleema

Create a Profile: Provide basic health information to get started.

Find a Match: Our platform identifies trials that align with your medical history and interests.

Connect & Enroll: A trial coordinator will get in touch to learn more and begin the enrollment process.

Who Can Participate?

Each clinical trial has unique eligibility criteria, but Embleema makes it easy to explore opportunities that align with your health background. Whether you are actively managing epilepsy or looking to support research, we help you find the right fit.

Contribute to Research Beyond Clinical Trials

Even if you don't match to a clinical trial, you can support epilepsy research by securely sharing your health data. Your insights help researchers:

Gain a deeper understanding of epilepsy and seizure patterns.

Share your health data securely with your care team.

Develop better treatment options and personalized therapies.

About the study team

Neuroventis is a digital health company specializing in neurological care. Their platform enhances patient engagement and remote monitoring, empowering individuals with neurological disorders to actively participate in their treatment. By facilitating seamless communication between patients and healthcare professionals, Neuroventis aims to improve treatment outcomes and advance neurology care.

Embleema, a New York-based healthcare technology company, has partnered with the Epilepsy Foundation to launch BET, a platform that consolidates patient health data, enables secure sharing with caregivers and researchers, and offers personalized insights for improved condition management. Embleema’s platform, trusted by the FDA, NIH, top U.S. health networks, and leading organizations, continues its commitment to empowering the epilepsy community.

Take the next step in advancing epilepsy research

Get Started